Send me a link:

*Text messaging rates may apply.

 Dow Down 0.52% Nasdaq Down 0.71%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
324.15 Up 7.93(2.51%) 11:44AM EDT - Nasdaq Real Time Price
Prev Close:316.22
Open:322.52
Bid:324.50 x 100
Ask:324.84 x 100
1y Target Est:346.78
Beta:0.86
Next Earnings Date: 5-Aug-14REGN Earnings announcement
Day's Range:320.43 - 328.73
52wk Range:227.64 - 352.49
Volume:646,861
Avg Vol (3m):1,192,650
Market Cap:32.00B
P/E (ttm):92.93
EPS (ttm):3.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for REGN

Comparison

Symbol% ChgMkt Cap
REGNUp 2.51%32.00B
AMGNDown 1.45%95.28B
NVSDown 0.10%210.72B
RHHBYDown 0.23%246.25B

Key Statistics

Forward P/E (1 yr):26.73
P/S (ttm):13.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :9.89
Quarterly EPS Est (Jun-14) :2.30
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.56

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback